With the US Food and Drug Administration’s (USFDA) recent authorisation of Novavax’s Nuvaxovid vaccine, SII has become the first Indian manufacturer to access the US vaccine market Read More
With the US Food and Drug Administration’s (USFDA) recent authorisation of Novavax’s Nuvaxovid vaccine, SII has become the first Indian manufacturer to access the US vaccine market